Background: The level of evidence for HIV transmission risk through condomless sex in serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral therapy (ART) is limited compared with the evidence available for transmission risk in heterosexual couples. The aim of the second phase of the PARTNER study (PARTNER2) was to provide precise estimates of transmission risk in gay serodifferent partnerships. Methods: The PARTNER study was a prospective observational study done at 75 sites in 14 European countries. The first phase of the study (PARTNER1; Sept 15, 2010, to May 31, 2014) recruited and followed up both heterosexual and gay serodifferent couples (HIV-positive partner taking suppressive ART) who repo...
Importance: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
Background: The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
BACKGROUND The level of evidence for HIV transmission risk through condomless sex in serodifferen...
Background: The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
BACKGROUND The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
BACKGROUND The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
BACKGROUND: The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
Importance A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral ther...
Importance: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
Background: The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
BACKGROUND The level of evidence for HIV transmission risk through condomless sex in serodifferen...
Background: The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
BACKGROUND The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
BACKGROUND The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
BACKGROUND: The level of evidence for HIV transmission risk through condomless sex in serodifferent ...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
Background The level of evidence for HIV transmission risk through condomless sex in serodifferent g...
Importance A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral ther...
Importance: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...
IMPORTANCE: A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral the...